MedPath

Short-term clinical outcome of robotic-assisted esophagectomy for esophageal cancer: a retrospective single-center analysis.

Conditions
C15
Malignant neoplasm of oesophagus
Registration Number
DRKS00028112
Lead Sponsor
niversitätsklinikum Münster (UKM)Klinik für Allgemein-, Viszeral- und Transplantationschirurgie
Brief Summary

This single-center, retrospective study employing propensity score matching found that combining robotic-assisted minimally invasive esophagectomy (RAMIE) with structured total mesoesophageal excision (TME) results in better short-term clinical and oncologic outcomes than open transthoracic esophagectomy without structured TME. This finding is significant because the increased rate of R0 resection could indicate a higher likelihood of improved long-term survival. Additionally, enhanced overall postoperative recovery may contribute to better risk management in esophagectomy procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
270
Inclusion Criteria

Patients after esophagectomy who underwent either open, hybrid-laparoscopic, or robotic-assisted surgery.

period retrospective:
01.01.2012-15.03.2022

Exclusion Criteria

1. pregnancy / lactation
2. premature termination of surgery in case of inoperability
3. active COVID-19 infection / HSV pneumonia
4. multiple-stage esophagectomy (different days)

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
30d mortality-rate, R0-resection rate, severe complication rate (Clavien-Dindo)
Secondary Outcome Measures
NameTimeMethod
- ICU and hospital stay<br>- laboratory values<br>- postoperative complication rate: anastomotic leak & pneumonia<br>- possible confounder
© Copyright 2025. All Rights Reserved by MedPath